2025-03-11 22:32:15
Latest Post
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Hexaware Inaugurates Global Business Headquarters in Jersey City
HCLTech among Ethisphere's 2025 World's Most Ethical Companies®
Ind-Swift Laboratories Ltd receives 'Best Employer Brand - Punjab 2025' by World HRD Congress
Stock Report
Advanced Enzyme Technologies Ltd consolidated Q2FY22 PAT declines to Rs. 29.69 crore
Posted On : 2021-11-02 12:43:57( TIMEZONE : IST )
Advanced Enzyme Technologies Limited has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 127.976 crores during the period ended September 30, 2021 as compared to Rs. 137.947 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 29.698 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 37.969 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 2.65 for the period ended September 30, 2021 as compared to Rs. 3.39 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 127.976 crs | ₹137.947 crs |  -7.23% |
| Net Profit | ₹29.698 crs | ₹37.969 crs | -21.78% |
| EPS | ₹2.65 | ₹3.39 | -21.83% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 127.976 crores during the period ended September 30, 2021 as compared to Rs.120.968 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.29.698 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.37.186 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.2.65 for the period ended September 30, 2021 as compared to Rs.3.33 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 127.976 crs | ₹120.968 crs |  5.79% |
| Net Profit | ₹29.698 crs | ₹37.186 crs | -20.14% |
| EPS | ₹2.65 | ₹3.33 | -20.42% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.265.923 crores during the 6 Months period ended September 30, 2021 as compared to Rs.236.703 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.67.666 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.71.435 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.6.04 for the 6 Months period ended September 30, 2021 as compared to Rs.6.39 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹265.923 crs | ₹236.703 crs | 12.34% |
| Net Profit | ₹67.666 crs | ₹71.435 crs | -5.28% |
| EPS | ₹6.04 | ₹6.39 | -5.48% |
Shares of Advanced Enzyme Technologies Limited was last trading in BSE at Rs. 384.95 as compared to the previous close of Rs. 376.25. The total number of shares traded during the day was 4430 in over 355 trades.
The stock hit an intraday high of Rs. 386.80 and intraday low of 374.30. The net turnover during the day was Rs. 1695032.00.
